Login / Signup

Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding.

Pia GattingerKristina BorochovaYulia DorofeevaRainer HenningRenata KissBernhard KratzerBernhard MühlThomas PerkmannDoris TrapinMartina TrellaPaul EttelInna TulaevaWinfried F PicklRudolph Valenta
Published in: Allergy (2020)
Keyphrases
  • end stage renal disease
  • coronavirus disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • sars cov
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes
  • binding protein
  • dna binding